01 Identity
Registration and reporting
- Registration status
- Registered
- Reporting status
- New
- Charity type
- CIO
- Registered
- 15 September 2026
- Removed
- Not supplied
- Financial period
- Not supplied – Not supplied
- Latest income
- Not supplied
- Latest expenditure
- Not supplied
- In administration
- No
- Insolvent
- No
- CIO
- Yes
Public contact address: 5 BEYON DRIVE, CAM, DURSLEY, GLOUCESTERSHIRE, GL11 5JW
Website recorded by the regulator: annasbreathofhope.com (displayed as text)
03 Official extract
Charity Area Of Operation
- Geographic Area Type
- Region
- Geographic Area Description
- Throughout England And Wales
- Welsh Ind
- No
04 Official extract
Charity Classification
- Classification Code
- 308
- Classification Type
- How
- Classification Description
- Sponsors Or Undertakes Research
- Classification Code
- 207
- Classification Type
- Who
- Classification Description
- The General Public/mankind
- Classification Code
- 103
- Classification Type
- What
- Classification Description
- The Advancement Of Health Or Saving Of Lives
- Classification Code
- 302
- Classification Type
- How
- Classification Description
- Makes Grants To Organisations
- Classification Code
- 307
- Classification Type
- How
- Classification Description
- Provides Advocacy/advice/information
- Classification Code
- 205
- Classification Type
- Who
- Classification Description
- Other Charities Or Voluntary Bodies
05 Official extract
Charity Event History
- Charity Name
- ANNA'S BREATH OF HOPE
- Charity Event Order
- 1
- Event Type
- CIO registration
- Date Of Event
- 2026-09-15T00:00:00
06 Official extract
Charity Governing Document
- Governing Document Description
- CIO - FOUNDATION Registered 15 Sep 2026
- Charitable Objects
- THE OBJECTS OF THE CIO ARE:TO RELIEVE SICKNESS AND PRESERVE HEALTH FOR THE PUBLIC BENEFIT, IN PARTICULAR BY:3.1. RAISING FUNDS TO SUPPORT AND ENABLE CLINICAL RESEARCH, TRIALS AND COLLABORATIVE MEDICAL INITIATIVES FOCUSED ON PULMONARY FIBROSIS AND RELATED LUNG CONDITIONS;3.2. FUNDING PROJECTS THAT IMPROVE UNDERSTANDING, DIAGNOSIS, TREATMENT AND OUTCOMES FOR PEOPLE LIVING WITH PULMONARY FIBROSIS AND RELATED LUNG CONDITIONS; AND 3.3. SUPPORTING COLLABORATION BETWEEN PATIENTS, CLINICIANS, RESEARCHERS AND INSTITUTIONS IN ORDER TO TRANSLATE RESEARCH INTO EFFECTIVE TREATMENTS.